ABSTRACT
The use of blood substitutes has been proposed as therapies for limiting tissue damage and facilitating survival, recovery, and eventual rehabilitation both within and outside the hospital as part of emergency medical or battlefield treatment. This entry provides some of the background of blood substitute therapies and discusses the risks and benefits associated with these types of therapies by presenting several examples of clinical trials and regulatory findings.
